AI-DRIVEN DRUG GENERATION
Powered By Award-Winning AI Drug Discovery Platform
We aim to advance current state-of-the-art AI drug discovery technologies and transform high-cost, low-efficiency drug discovery practices into rapid, efficient discovery, ultimately leading to high success rates in the clinical phase.
We aim to advance current state-of-the-art AI drug discovery technologies and transform high-cost, low-efficiency drug discovery practices into rapid, efficient discovery, ultimately leading to high success rates in the clinical phase.
Our award-winning AI drug discovery platform enables the direct discovery of high potency drugs that induce desired cellular-level activity with minimal off-target effects and toxicity.
Our award-winning AI drug discovery platform enables the direct discovery of high potency drugs that induce desired cellular-level activity with minimal off-target effects and toxicity.
AIGEN Sciences will revolutionize AI-based drug discovery.
AIGEN Sciences will revolutionize AI-based drug discovery.
Achievements
Achievements
Awards
Research Collaboration
Note: Prior to the establishment of AIGEN Sciences Inc.(Apr 2021), the accomplishments were made through KU (Korea Univ) DMIS Lab. AIGEN Sciences Inc. is a spin-off of KU DMIS.
History
History
2023
2023
Jan.
Jan.
Research Collaboration with YUHAN
: Anti-cancer drugs mechanism identification
Research Collaboration with YUHAN
: Anti-cancer drugs mechanism identification
2022
2022
Nov.
Nov.
Research Collaboration with NOVELTY NOBILITY Inc.
: Novel ADC payload development
Research Collaboration with NOVELTY NOBILITY Inc.
: Novel ADC payload development
2022
2022
Oct.
Oct.
Raised KRW 4.2B in pre-series A funding
Raised KRW 4.2B in pre-series A funding
2022
2022
May.
May.
MOU with K-Medi HUB: Collaboration for AI-based innovative drug development
MOU with K-Medi HUB: Collaboration for AI-based innovative drug development
2022
2022
Feb.
Feb.
Research Collaboration with Incurix: Transcription factor inhibitor development
Research Collaboration with Incurix: Transcription factor inhibitor development
2022
2022
Jan.
Jan.
Sponsored Research with Avelos Therapeutics: Anti-cancer drug discovery
Sponsored Research with Avelos Therapeutics: Anti-cancer drug discovery
2021
2021
Nov.
Nov.
Government Research Project with LMITO Therapeutics
Government Research Project with LMITO Therapeutics
Granted by Korea Drug Development Fund (KDDF), a government-initiated drug development program.
Granted by Korea Drug Development Fund (KDDF), a government-initiated drug development program.
2021
2021
Nov.
Nov.
Winning 1st and 3rd place: BioCreative VII Challenge
Collaboration with KU and AstraZeneca
Winning 1st and 3rd place: BioCreative VII Challenge
Collaboration with KU and AstraZeneca
Outperforming ETH, NVIDIA
2021
2021
Apr.
Apr.
Reseach Collaboration with LMITO Therapeutics : Autoimmune diseases
Reseach Collaboration with LMITO Therapeutics : Autoimmune diseases
Apr.
Apr.
AIGEN Sciences Established
AIGEN Sciences Established
2020
2020
Oct.
Oct.
Winning 1st place: BioASQ Biomedical Semantic Indexing and Question Answering
Winning 1st place: BioASQ Biomedical Semantic Indexing and Question Answering
Outperforming UCSD, UMass-Chan Zuckerberg Initiative
Jun.
Jun.
Joint Research with Global Big Pharma "A" : AI for Biomedical Natural Language Processing
Joint Research with Global Big Pharma "A" : AI for Biomedical Natural Language Processing
Apr.
Apr.
Research Collaboration with Donga -ST : Rare neurovascular diseases therapeutics
Research Collaboration with Donga -ST : Rare neurovascular diseases therapeutics
Feb.
Feb.
Research Collaboration with LMITO Therapeutics : Neurodegenerative diseases therapeutics
Research Collaboration with LMITO Therapeutics : Neurodegenerative diseases therapeutics
2019
2019
Nov.
Nov.
Research Collaboration with Crystal Genomics : Immunotherapeutics combination
Research Collaboration with Crystal Genomics : Immunotherapeutics combination
Nov.
Nov.
Winning 1st place: IDG-DREAM Drug-Kinase Binding Prediction Challenge
Joint 1st place with UIUC, UNC Chapel Hill
Sep.
Sep.
Winning 1st place: BioASQ Biomedical Semantic Indexing and Question Answering
Winning 1st place: BioASQ Biomedical Semantic Indexing and Question Answering
Outperforming Google (2nd place)
2018
2018
Dec.
Dec.
Winning 1st place: Multi-targeting Drug DREAM Challenge
Winning 1st place: Multi-targeting Drug DREAM Challenge
Outperforming Janssen Pharmaceuticals (4th place)
2017
2017
Nov.
Nov.
Winning 1st place: NCI-CPTAC DREAM Proteogenomics Challenge
Winning 1st place: NCI-CPTAC DREAM Proteogenomics Challenge
Outperforming UCLA (2nd place) and MD Anderson (16th place)
2016
2016
Oct.
Oct.
Winning 2nd place: Disease Module Identification DREAM Challenge
Winning 2nd place: Disease Module Identification DREAM Challenge
Outperforming Stanford (11th place) and Yale (18th place)
Mar.
Mar.
Winning 2nd place: AstraZeneca-Sanger Drug Combination Prediction Challenge
Winning 2nd place: AstraZeneca-Sanger Drug Combination Prediction Challenge
Outperforming Stanford (6th place) and MIT (11th place)
